Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine
- 1 April 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 110 (3) , 357-361
- https://doi.org/10.1016/0014-2999(85)90564-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Role of Amantadine in the Management of Neuroleptic-Induced Extrapyramidal SyndromesClinical Neuropharmacology, 1983
- Effect of chronic phencyclidine or d-amphetamine treatment on [3H]spiroperidol binding in rat caudate-putamen and nucleus accumbensEuropean Journal of Pharmacology, 1982
- Amantadine reduces haloperidol-induced dopamine receptor hypertensitivity in the striatumEuropean Journal of Pharmacology, 1980
- 3H-spiroperidol labels dopamine receptors in pituitary and brainEuropean Journal of Pharmacology, 1977
- STUDIES ON THE MECHANISM OF ACTION OF AMANTADINEBritish Journal of Pharmacology, 1976
- Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan)Psychopharmacology, 1975
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973
- Evaluation of amantadine as a releasing agent or uptake blocker for H3-dopamine in rat brain slicesEuropean Journal of Pharmacology, 1972
- Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the ratBiochemical Pharmacology, 1972
- Evidence for dopamine receptor stimulation by apomorphineJournal of Pharmacy and Pharmacology, 1967